Neurocrine Biosciences, Inc.
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS

Last updated:

Abstract:

Provided are methods of administering a catechol-O-methyltransferase (COMT) inhibitor chosen from opicapone, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof wherein the patient is already being administered quinidine or is suffering from a disease or disorder treatable by quinidine.

Status:
Application
Type:

Utility

Filling date:

4 Oct 2019

Issue date:

4 Nov 2021